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Background:
 
 Acute myocarditis (AM) is a rare and potentially lethal con-
dition for which diagnosis and treatment remain challenging. The recent H1N1
flu pandemic was an opportunity to improve our knowledge about this patho-
logy.
 
Methods:
 
 Since October 2009, we have prospectively enrolled patients
diagnosed with AM from intensive care units and cardiology departments in
France using the following criteria : anatomo-pathological proof of AM OR
presence of infectious context and >1 cardiac symptom and abnormal troponin
level and abnormal ECG, echo or cardiac MRI and absence of significant
coronary artery disease.
 
Results:
 
 71 patients (59 male, mean age 39±20) have been enrolled. Pre-
senting symptoms were chest pain (77,5%), dyspnea (33,8%), cardiogenic
shock (11,3%) and conduction disorder or significant arrhythmia (8,4%). ST
segment or T wave changes were present in 88,7%. Mean troponin and CRP
levels were 9,1±9,8 
 
μ
 
g/l and 56±59 mg/l, respectively. Echocardiography
showed a mean ejection fraction of 51±15%, wall motion abnormalities in
39%, and pericardial effusion in 18%. In 62% of cases, cardiac MRI was per-
formed showing oedema (43%) and late enhancement (68%). Only 3 patients
underwent a biopsy. Complications were congestive heart failure (22,5%) and
ventricular arrhythmia (7%). Two patients died before hospital discharge.
Viral origin of the AM was proven or presumed in 83% of patients, including
4 diagnosed with H1N1 flu. Treatment generally included beta-blockers, ACE
inhibitors and aspirin.
 
Conclusion:
 
 AM affects mainly young patients whose prognosis may be
compromised by severe complications. Follow-up of this registry will provide
insight into the prognosis and the long-term impact of medical therapy. 
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Background:
 
 Heart rate recovery (HRR) prognostic value is well esta-
blished in patients with coronary artery disease but poorly documented in
patients with heart failure (HF) and not established in those with advanced HF. 
 
Methods:
 
 144 patients with compensated HF underwent cardiopulmonary
exercise testing (CPX) and were followed for a combined death/ transplanta-
tion/ hospitalization end point. Patients with advanced HF were defined as
those with peak VO2
 
≤
 
 14ml/kg/mn (n= 41/144; 28%). Mean age and left ven-
tricular ejection fraction (LVEF) were 53±12 years and 29±7% respectively in
all population and 58±11 years and 28±7% respectively in the advanced HF
group. Ninety one percent of patients received betablockers (93% in advanced
HF group). HRR at 1-minute post-CPX was calculated as the difference
between heart rate at peak exercise and after 1 minute of active recovery. 
 
Results:
 
 Among the 144 patients, we recorded 10 mortality, 7 cardiac
transplantation and 8 hospitalization for acute HF outcome events over 16
months of follow-up. The baseline mean peak respiratory exchange ratio
(RER), peak VO2, VE/VCO2 slope, and HRR1 were 1.13±0.09, 16±4 ml/kg/
mn, 35±8, 13±12 beat/mn, respectively. Although LVEF, peak VO2, VE/
VCO2 slope and HRR1 were significant univariate predictors of the composite
end point (p<0.05), multivariate Cox regression analysis only retained LVEF
(chi2 = 5.5, p=0.01) and HRR1 (chi2 = 5.2, p= 0.02) in the equation. In the
group of patients with advanced HF the mean peak RER, peak VO2, VE/
VCO2 slope, and HRR1 were 1.10±0.07, 12±1 ml/kg/mn, 39±11, 9±8 beat/
mn, respectively. Kaplan-Meier analysis revealed a significant difference in
survival according to a 5 bpm HRR1 threshold: 68% in patients with HRR1
 
≤
 
5 bpm vs 96% in those with HRR1> 5bpm (logrank=5, p=0.02) (HR= 2.66;
CI: 2.08-2.66, p=0.02). 
 
Conclusions:
 
 HRR is an easily measured noninvasive variable that can be
used to further prognostically risk stratify patients with advanced HF. 
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Background:
 
 Patients with heart failure (HF) and peak oxygen consump-
tion (pVO2) < 10 ml/kg/mn have a very poor prognosis whereas those with a
pVO2 >18 ml/kg/mn have a very good prognosis. However, there remains a
“grey zone” of intermediate pVO2 values between 10 and 18ml/kg/mn which
needs to be further stratified. The aim of the study is to evaluate whether
patients with intermediate pVO2 values can be more accurately assessed in
terms of prognosis using heart rate recovery (HRR). 
 
Methods:
 
 92 patients with compensated HF with 10< pVO2
 
≤
 
 18ml/kg/mn
at cardiopulmonary exercise testing (CPX) were followed for a combined
death/ transplantation/ hospitalisation end point. Mean age and left ventricular
ejection fraction (LVEF) were 54±12 years and 30±6% respectively. Ninety
one percent of patients received betablockers. Heart rate at 1-minute post-CPX
(HRR1) was calculated as the difference between heart rate at peak exercise
and after 1 minute of active recovery. 
 
Results:
 
 We recorded 5 mortality, 4 cardiac transplantation and 5 hospita-
lisation for acute HF outcome events over 16 months of follow-up. The base-
line mean peak respiratory exchange ratio (RER), pVO2, minute ventilation/
carbon dioxide production (VE/VCO2) slope, and HRR1 were 1.14±0.10,
14.7±2.0 ml/kg/mn, 36.6±8.5, 12±13 beat/mn respectively. Although LVEF,
VE/VCO2 slope and HRR1 were significant univariate predictors of the com-
posite end point (p<0.01), multivariate Cox regression analysis only retained
the HRR1 in the equation (chi2 = 5.07, HR= 2.39, CI: 2.19-2.68, p= 0.02).
Kaplan-Meier analysis revealed a significant difference in event-free survival
according to a 7 bpm HRR1 cut-off: 65 % in patients with HRR1
 
≤
 
 7 bpm vs
96% in those with HRR1> 7 bpm (logrank=14, p=0.0002) (HR= 2.53; CI:
2.42-2.65, p=0.003).
 
Conclusions:
 
 HRR1 is an easily measured noninvasive variable that can be
used to further prognostically risk stratify patients with HF and intermediate
peak oxygen consumption (10< pVO2
 
≤
 
 18ml/kg/mn).
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Objectives:
 
 To investigate the impact of LV dyssynchrony on exercise
capacity in patients with hypertrophic cardiomyopathy (HCM) and preserved
left ventricular ejection fraction (LVEF>50%).
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